New Oral Anticoagulants: What Prescribers Should Know; Differences and Similarities between Warfarin and "New Agents" (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) - Review of Indications, Contraindications and Safety of Use.
作者信息
Petrasko Marian, Raizada Amol, Petraskova Terezia
机构信息
Cardiovascular Disease Fellowship Program, University of South Dakota Sanford School of Medicine.
School of Arts, Washington University, St. Louis, Missouri.
出版信息
S D Med. 2016 Aug;69(8):363-369.
PMID:28806005
Abstract
摘要
Zotero 插件